Search research articles
Contact Us
Filters
Showing results (211-220 of 442) with videos related to
Page
of 45
Sort By:
JCO Precision Oncology
|
July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With Cancer
Kyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
The Oncologist
|
March 17, 2021
Overview of Ocular Side Effects of Selinexor
Nagham Al-Zubidi, Dan S Gombos, David S Hong, et al.
Cancer Genetics
|
December 20, 2021
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib
Erin R Rudzinski, Jaclyn Hechtman, Sinchita Roy-Chowdhuri, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer
Apostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
The Oncologist
|
October 25, 2013
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit
Siqing Fu, Lacey McQuinn, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses
Apostolia-Maria Tsimberidou, Sijin Wen, David S Hong, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Oncotarget
|
July 9, 2014
Characteristics and survival of patients with advanced cancer and p53 mutations
Rabih Said, Yang Ye, David S Hong, et al.
Oncotarget
|
May 15, 2013
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy
Rabin Said, David S Hong, Carla L Warneke, et al.
Investigational New Drugs
|
April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy
Mehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
Page
of 45
Search research articles
Search
Showing results (211-220 of 442) with videos related to
Sort By:
Page
of 45
JCO Precision Oncology
|
July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With Cancer
Kyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
The Oncologist
|
March 17, 2021
Overview of Ocular Side Effects of Selinexor
Nagham Al-Zubidi, Dan S Gombos, David S Hong, et al.
Cancer Genetics
|
December 20, 2021
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib
Erin R Rudzinski, Jaclyn Hechtman, Sinchita Roy-Chowdhuri, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer
Apostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
The Oncologist
|
October 25, 2013
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit
Siqing Fu, Lacey McQuinn, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses
Apostolia-Maria Tsimberidou, Sijin Wen, David S Hong, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Oncotarget
|
July 9, 2014
Characteristics and survival of patients with advanced cancer and p53 mutations
Rabih Said, Yang Ye, David S Hong, et al.
Oncotarget
|
May 15, 2013
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy
Rabin Said, David S Hong, Carla L Warneke, et al.
Investigational New Drugs
|
April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy
Mehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
Page
of 45